 |
Mononuclear enriched fraction of human umbilical cord blood |
|---|---|
| Trade Name | U-Cord-Cell(R) |
| Orphan Indication | Amyotrophic lateral sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2015-09-15 00:00:00 |
| Sponsor | Saneron CCEL Therapeutics, Inc.;13014 North Dale Mabry Highway, Suite 266;Tampa, Florida, 33618 |
